This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Blood transfusion (dilutional thrombocytopenia)

Authoring team

Stored blood is subject to considerable loss of functional platelets and labile coagulation factors - e.g. Factors II, V and VII - but not fibrinogen or Factors II, VII, IX, X and XI.

Large volume transfusion of such blood may result in:

  • dilutional thrombocytopenia
  • disseminated intravascular coagulopathy - often attributed to the underlying or associated conditions
  • impaired platelet function

Laboratory investigations reveal:

  • increased PT, APTT, bleeding time
  • reduced plasma levels of fibrinogen, Factors V and VIII
  • thrombocytopenia

Management:

  • review patient's clinical condition; underlying disease; presence of anatomical bleeding lesions; results of coagulation tests
  • consider fresh frozen plasma - which contains the plasma proteins and labile clotting factors
  • consider cryoprecipitate - rich in Factor VIII and fibrinogen - especially if DIC is evident as fibrinogen is required in addition to clotting factors

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.